These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Patients' competency to give informed consent to medication. Beck JC; Staffin RD Hosp Community Psychiatry; 1986 Apr; 37(4):400-2. PubMed ID: 2870979 [No Abstract] [Full Text] [Related]
5. Tardive dyskinesia and informed consent: myths and realities. Munetz MR; Roth LH; Cornes CL Bull Am Acad Psychiatry Law; 1982; 10(2):77-88. PubMed ID: 6129012 [No Abstract] [Full Text] [Related]
6. Informed consent and tardive dyskinesia. Kleinman I; Schachter D; Koritar E Am J Psychiatry; 1989 Jul; 146(7):902-4. PubMed ID: 2568093 [TBL] [Abstract][Full Text] [Related]
7. Psychiatrists' documentation of informed consent. Schachter D; Kleinman I Can J Psychiatry; 1998 Dec; 43(10):1012-7. PubMed ID: 9868566 [TBL] [Abstract][Full Text] [Related]
8. Legal aspects of neuroleptic-induced movement disorders. Wettstein RM Leg Med; 1985; ():117-79. PubMed ID: 2872562 [No Abstract] [Full Text] [Related]
9. The issue of informed consent and the use of neuroleptic medications. Turnquist AC Int J Nurs Stud; 1983; 20(3):181-6. PubMed ID: 6140242 [No Abstract] [Full Text] [Related]
10. Psychotic patients' understanding of informed consent. Irwin M; Lovitz A; Marder SR; Mintz J; Winslade WJ; Van Putten T; Mills MJ Am J Psychiatry; 1985 Nov; 142(11):1351-4. PubMed ID: 2865904 [TBL] [Abstract][Full Text] [Related]
11. Information and consent in schizophrenic patients in long-term treatment. Linden M; Chaskel R Schizophr Bull; 1981; 7(3):372-8. PubMed ID: 6116275 [TBL] [Abstract][Full Text] [Related]
12. Tardive dyskinesia: legal issues and consent. Gupta S; Frank B; Madhusoodanan S Psychiatr Ann; 2002 Apr; 32(4):245-8. PubMed ID: 12774783 [No Abstract] [Full Text] [Related]
13. Informed consent in psychiatric research: preliminary findings from an ongoing investigation. Benson PR; Roth LH; Winslade WJ Soc Sci Med; 1985; 20(12):1331-41. PubMed ID: 2862705 [TBL] [Abstract][Full Text] [Related]
14. Drug information disclosed to patients prescribed antipsychotic medication. Benson PR J Nerv Ment Dis; 1984 Nov; 172(11):642-53. PubMed ID: 6149255 [TBL] [Abstract][Full Text] [Related]
15. U.S. v. Charters. Bourke LH Issues Law Med; 1990; 6(3):309-11. PubMed ID: 1980676 [No Abstract] [Full Text] [Related]
16. The effect of psychopathology on the ability of schizophrenic patients to give informed consent. Schachter D; Kleinman I; Prendergast P; Remington G; Schertzer S J Nerv Ment Dis; 1994 Jun; 182(6):360-2. PubMed ID: 7911156 [No Abstract] [Full Text] [Related]
17. Reconsidering "psychosurgery": issues of informed consent and physician responsibility. Stagno SJ; Smith ML; Hassenbusch SJ J Clin Ethics; 1994; 5(3):217-23. PubMed ID: 7841471 [No Abstract] [Full Text] [Related]
18. [The law of informed consent and its impasses in psychiatry]. Garneau Y; Diener JM Can J Psychiatry; 1989 Nov; 34(8):759-64. PubMed ID: 2573413 [TBL] [Abstract][Full Text] [Related]
19. Is it best to obtain informed consent from schizophrenic patients about the possible risk of drug treatment, for example, tardive dyskinesia, before initiating treatment or at a later date? Roth LH J Clin Psychopharmacol; 1983 Jun; 3(3):207-8. PubMed ID: 6135724 [No Abstract] [Full Text] [Related]
20. The right to refuse: informed consent and the psychosocial nurse. Weiss FS J Psychosoc Nurs Ment Health Serv; 1990 Aug; 28(8):25-30. PubMed ID: 2398483 [No Abstract] [Full Text] [Related] [Next] [New Search]